TY - JOUR
T1 - History of chickenpox in glioma risk
T2 - a report from the glioma international case–control study (GICC)
AU - Amirian, E. Susan
AU - Scheurer, Michael E.
AU - Zhou, Renke
AU - Wrensch, Margaret R.
AU - Armstrong, Georgina N
AU - Lachance, Daniel
AU - Olson, Sara H.
AU - Lau, Ching C.
AU - Claus, Elizabeth B.
AU - Barnholtz-Sloan, Jill S
AU - Il'yasova, Dora
AU - Schildkraut, Joellen
AU - Ali-Osman, Francis
AU - Sadetzki, Siegal
AU - Jenkins, Robert B.
AU - Bernstein, Jonine L.
AU - Merrell, Ryan T.
AU - Davis, Faith G.
AU - Lai, Rose
AU - Shete, Sanjay
AU - Amos, Christopher I.
AU - Melin, Beatrice S.
AU - Bondy, Melissa L.
N1 - Publisher Copyright:
© 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Varicella zoster virus (VZV) is a neurotropic α-herpesvirus that causes chickenpox and establishes life-long latency in the cranial nerve and dorsal root ganglia of the host. To date, VZV is the only virus consistently reported to have an inverse association with glioma. The Glioma International Case-Control Study (GICC) is a large, multisite consortium with data on 4533 cases and 4171 controls collected across five countries. Here, we utilized the GICC data to confirm the previously reported associations between history of chickenpox and glioma risk in one of the largest studies to date on this topic. Using two-stage random-effects restricted maximum likelihood modeling, we found that a positive history of chickenpox was associated with a 21% lower glioma risk, adjusting for age and sex (95% confidence intervals (CI): 0.65–0.96). Furthermore, the protective effect of chickenpox was stronger for high-grade gliomas. Our study provides additional evidence that the observed protective effect of chickenpox against glioma is unlikely to be coincidental. Future studies, including meta-analyses of the literature and investigations of the potential biological mechanism, are warranted.
AB - Varicella zoster virus (VZV) is a neurotropic α-herpesvirus that causes chickenpox and establishes life-long latency in the cranial nerve and dorsal root ganglia of the host. To date, VZV is the only virus consistently reported to have an inverse association with glioma. The Glioma International Case-Control Study (GICC) is a large, multisite consortium with data on 4533 cases and 4171 controls collected across five countries. Here, we utilized the GICC data to confirm the previously reported associations between history of chickenpox and glioma risk in one of the largest studies to date on this topic. Using two-stage random-effects restricted maximum likelihood modeling, we found that a positive history of chickenpox was associated with a 21% lower glioma risk, adjusting for age and sex (95% confidence intervals (CI): 0.65–0.96). Furthermore, the protective effect of chickenpox was stronger for high-grade gliomas. Our study provides additional evidence that the observed protective effect of chickenpox against glioma is unlikely to be coincidental. Future studies, including meta-analyses of the literature and investigations of the potential biological mechanism, are warranted.
KW - Brain tumor
KW - chickenpox
KW - glioma
KW - shingles
UR - https://www.scopus.com/pages/publications/84991522623
U2 - 10.1002/cam4.682
DO - 10.1002/cam4.682
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 26972449
AN - SCOPUS:84991522623
SN - 2045-7634
VL - 5
SP - 1352
EP - 1358
JO - Cancer Medicine
JF - Cancer Medicine
IS - 6
ER -